By proceeding, you agree to our Terms of Use and Privacy Policy.
Cancer. Diabetes. Alzheimer’s. Heart Disease. Parkinson’s. The Jackson Laboratory (JAX) leads the search to cure diseases rooted in our DNA.
25-27 January 2022
Validate Your Preclinical Hypothesis by Dissecting Solid Tumor Microenvironment, Predictive Biomarker, Safety & Clinical Efficacy Analysis through Next Gen Models & Bioinformatics The last 12 months witnessed the surge of exciting combination immuno-
Event Ended
Virtual
Paid
22-24 February 2022
Stakeholders across oncology and beyond are now turning to next generation developments and technology to create the therapies of tomorrow, NOW! That’s why CAR-TCR Europe has evolved into the Next Generation CAR-TCR Summit. the only industry-de
UK
London
26-28 April 2022
The 2nd Fc Receptor & IgG Targeted Therapies Summit is your definitive meeting for the most up-to-date clinical and commercial developments on pioneering strategies to modulate FcRs and harness their full therapeutic potential.
USA
Boston
12-14 July 2022
From Leveraging Emerging Predictive Technologies to Engineering a Human-Physiologically Relevant Models – Deepen Our Understanding of Tumor Biology, Resistance Mechanisms & Dosing Strategy Following the success of KRAS, HER2, BCMA, drug developers ha
26-26 July 2022
Evaluating toxic response in the context of immunomodulatory treatments continues to challenge the drug development community. Measuring if novel therapeutics have the potential to evoke a critical toxic response in the clinic is extremely difficult.
Free
26-29 July 2022
With a plethora of cytokine-based modalities and targets storming across biopharma, the complexities and interactions of cytokines involved in the immune system is an exciting opportunity for all. From understanding biology to discovering and combini
19-22 September 2022
Across 3 main conference days and 8 tracks, 200+ CAR and TCR experts will lead you and your peers in discussions from novel allogeneic approaches with enhanced safety considerations, the latest in vivo gene engineering techniques, and advances in CMC
25-27 October 2022
Welcome to the 6th Annual Gene Therapy for Rare Disorders Europe Summit 2022 Gain European Regulatory Clarity to Progress Efficient & Robust Gene Therapies for Rare Disease As more and more companies gear up for clinical activity and near approval de
05-08 December 2022
This December, the 4th Annual Gene Therapy for Neurological Disorders meeting is returning to Boston to welcome discovery, preclinical, translational and clinical industry scientists to share, learn and network for the shared goal of successfully and
07-08 December 2022
With next generation of complex immuno-oncology candidates, preclinical and translational scientists in the IO space are in need for more predictive tumour models to improve clinical translatability, accelerating speed-to-clinic with confidence.
24-26 January 2023
With 2023 on track to see further growth in the immuno-oncology field, the availability of tools that offers drug developers & researchers advantages that weren’t available to them even a few years ago is increasing rapidly.
San Francisco
21-23 February 2023
Join us in London this February to connect with those trailblazing the next wave of CAR and TCR based approaches from pre-clinical development with in vivo engineering and regulatory fast-track strategies to streamlined analytics and automation to ma
15-19 May 2023
The world’s largest gathering of protein engineering and biotherapeutics experts is back in Boston! PEGS Boston Summit is the leading biologics event with comprehensive programming covering all aspects of biologic drug development with in-depth prese
Hybrid